Cargando…

Liraglutide in polycystic ovary syndrome: a randomized trial, investigating effects on thrombogenic potential

Polycystic ovary syndrome (PCOS) is associated with increased risk of venous thromboembolism (VTE) and cardiovascular disease (CVD) in later life. We aimed to study the effect of liraglutide intervention on markers of VTE and CVD risk, in PCOS. In a double-blind, placebo-controlled, randomized trial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nylander, Malin, Frøssing, Signe, Kistorp, Caroline, Faber, Jens, Skouby, Sven O
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424770/ https://www.ncbi.nlm.nih.gov/pubmed/28119323 http://dx.doi.org/10.1530/EC-16-0113

Ejemplares similares

Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS
por: Frøssing, Signe, et al.
Publicado: (2017)

Metformin as an initial adjunct to low-dose liraglutide enhances the weight-decreasing potential of liraglutide in obese polycystic ovary syndrome: Randomized control study
por: JENSTERLE, MOJCA, et al.
Publicado: (2016)

Liraglutide and polycystic ovary syndrome: is it only a matter of body weight?
por: Pugliese, G., et al.
Publicado: (2023)

The Effect of Liraglutide on Weight Loss in Women with Polycystic Ovary Syndrome: An Observational Study
por: Rasmussen, Christina B., et al.
Publicado: (2014)

The effects of treatment with liraglutide on atherothrombotic risk in obese young women with polycystic ovary syndrome and controls
por: Kahal, Hassan, et al.
Publicado: (2015)

Endogenous Testosterone Levels Are Associated with Risk of Type 2 Diabetes in Women without Established Comorbidity
por: Rasmussen, Jon J, et al.
Publicado: (2020)

Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome
por: Xing, Chuan, et al.
Publicado: (2022)

Psychological investigation in patients with polycystic ovary syndrome
por: Bazarganipour, Fatemeh, et al.
Publicado: (2013)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

Investigation of Demodex folliculorum frequency in patients with polycystic ovary syndrome
por: Eser, Ayla, et al.
Publicado: (2017)

Potential genetic polymorphisms predicting polycystic ovary syndrome
por: Chen, Yao, et al.
Publicado: (2018)

The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome
por: Anala, Alekya Devi, et al.
Publicado: (2023)

Device Thrombogenicity Emulation: An In Silico Predictor of In Vitro and In Vivo Ventricular Assist Device Thrombogenicity
por: Chiu, Wei Che, et al.
Publicado: (2019)

Mendelian Randomization Analysis Identified Potential Genes Pleiotropically Associated with Polycystic Ovary Syndrome
por: Sun, Qian, et al.
Publicado: (2021)

Pregnancy in polycystic ovary syndrome
por: Kamalanathan, Sadishkumar, et al.
Publicado: (2013)

The inositols and polycystic ovary syndrome
por: Kalra, Bharti, et al.
Publicado: (2016)

On the Therapy for Polycystic Ovary Syndrome
por: Unfer, Vittorio, et al.
Publicado: (2017)

Kisspeptin and Polycystic Ovary Syndrome
por: Tang, Rong, et al.
Publicado: (2019)

Polycystic Ovary Syndrome in Adolescence
por: Deans, Rebecca
Publicado: (2019)

Update on polycystic ovary syndrome
por: Kim, Jin Ju
Publicado: (2021)

Quercetin and polycystic ovary syndrome
por: Ma, Congshun, et al.
Publicado: (2022)

An Investigation of Steroid Biosynthesis Pathway Genes in Women with Polycystic Ovary Syndrome
por: Sharma, Priyal, et al.
Publicado: (2022)

Investigation of the effects of astaxanthin in experimental polycystic ovary syndrome (PCOS) in rats
por: Toktay, Erdem, et al.
Publicado: (2023)

Quality of reporting of randomized controlled trials in polycystic ovary syndrome
por: Partsinevelou, Anna, et al.
Publicado: (2009)

Clinical and Biochemical Potential of Antioxidants in Treating Polycystic Ovary Syndrome
por: Cheng, Xiangyi, et al.
Publicado: (2022)

Ovarian Torsion in Polycystic Ovary Syndrome: A Potential Threat?
por: Psilopatis, Iason, et al.
Publicado: (2023)

Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin
por: Jensterle Sever, Mojca, et al.
Publicado: (2014)

Changes in Serum Cytokines Throughout Pregnancy in Women With Polycystic Ovary Syndrome
por: Stokkeland, Live Marie T, et al.
Publicado: (2021)

A Cross-Sectional Investigation of Quality of Life in Patients with Polycystic Ovary Syndrome
por: Tekin, Atilla, et al.
Publicado: (2018)

SAT-024 Investigating Racial and Ethnic Comorbidity Patterns of Polycystic Ovary Syndrome
por: Actkins, Ky’Era, et al.
Publicado: (2020)

Investigation of allele frequencies of polymorphic variants in genes that are related to polycystic ovary syndrome
por: Adam, Abdulkadir Rabiu, et al.
Publicado: (2022)

Expression of SET Protein in the Ovaries of Patients with Polycystic Ovary Syndrome
por: Boqun, Xu, et al.
Publicado: (2013)

Treatment options for polycystic ovary syndrome
por: Badawy, Ahmed, et al.
Publicado: (2011)

Adiponectin in Women with Polycystic Ovary Syndrome
por: Shin, Hyun-Young, et al.
Publicado: (2011)

Complementary Therapy in Polycystic Ovary Syndrome
por: Aquino, C. I., et al.
Publicado: (2014)

Features of Polycystic Ovary Syndrome in adolescence
por: Tsikouras, P, et al.
Publicado: (2015)

Dyslipidemia in women with polycystic ovary syndrome
por: Kim, Jin Ju, et al.
Publicado: (2013)

Cardiometabolic risk in polycystic ovary syndrome
por: Bajuk Studen, Katica, et al.
Publicado: (2018)

Polycystic ovary syndrome and mitochondrial dysfunction
por: Zhang, Jingshun, et al.
Publicado: (2019)

Polycystic Ovary Syndrome and Psychotic Disorder
por: Doretto, Larissa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hin7arc94uerdopniije74h41j